🔴 Tvardi Therapeutics is trading 5.8% down today as specific catalyst remains unclear

Tvardi Therapeutics is trading 5.8% down at $1.63, despite biotechnology and major U.S. indexes moving higher; the specific catalyst remains unclear.

• The stock has declined from $1.73 on September 16, 2026.
• No company-specific announcement dated September 17 appears on the company’s investor-relations release list.
• The latest listed release was the August 26 investor-events update; the move may reflect stock-specific selling or liquidity.